A survey of people from 31 different countries around the world found that mental health was the biggest health problem respondents said was facing their country in 2024. Other health problems reported by respondents included cancer, stress, and obesity. The COVID-19 pandemic The COVID-19 pandemic impacted almost every country in the world and was the biggest global health crisis in recent history. It resulted in hundreds of millions of cases and millions of deaths, causing unprecedented disruption in health care systems. Lockdowns imposed in many countries to halt the spread of the virus also resulted in a rise of mental health issues as feelings of stress, isolation, and hopelessness arose. However, vaccines to combat the virus were developed at record speed, and many countries have now vaccinated large shares of their population. Nevertheless, in 2024, ** percent of respondents still stated that COVID-19 was the biggest health problem facing their country. Mental health issues One side effect of the COVID-19 pandemic has been a focus on mental health around the world. The two most common mental health issues worldwide are anxiety disorders and depression. In 2021, it was estimated that around *** percent of the global population had an anxiety disorder, while **** percent suffered from depression. Rates of depression are higher among females than males, with some *** percent of females suffering from depression, compared to *** percent of men. However, rates of suicide in most countries are higher among men than women. One positive outcome of the COVID-19 pandemic and the spotlight it shined on mental health may be a decrease in stigma surrounding mental health issues and seeking help for such issues. This would be a positive development as many people around the world do not or cannot receive the necessary treatment they need for their mental health.

According to the 2024 survey, 46 percent of adults worldwide stated access to treatment and/or long waiting times was the biggest problem facing the healthcare system in their country. Another 45 percent of adults mentioned that lack of staff was the biggest issue. This statistic shows the percentage of adults worldwide who stated select issues were the biggest problems facing the healthcare system in their country as of 2024.

A survey of men from 31 different countries around the world found that mental health was the biggest health problem respondents from all generations except boomers said was facing their country in 2024. Approximately 44 percent of male boomers surveyed felt cancer was the biggest health problem facing their country, as opposed to only 28 percent of male Gen Z respondents.

A 2024 survey found that over half of U.S. individuals indicated the cost of accessing treatment was the biggest problem facing the national healthcare system. This is much higher than the global average of 32 percent and is in line with the high cost of health care in the U.S. compared to other high-income countries. Bureaucracy along with a lack of staff were also considered to be pressing issues. This statistic reveals the share of individuals who said select problems were the biggest facing the health care system in the United States in 2024.

Changelog:

Update September 20, 2021: Data and overview updated to reflect data used in the September 15 story Over Half of States Have Rolled Back Public Health Powers in Pandemic. It includes 303 state or local public health leaders who resigned, retired or were fired between April 1, 2020 and Sept. 12, 2021. Previous versions of this dataset reflected data used in the Dec. 2020 and April 2021 stories.

Overview

Across the U.S., state and local public health officials have found themselves at the center of a political storm as they combat the worst pandemic in a century. Amid a fractured federal response, the usually invisible army of workers charged with preventing the spread of infectious disease has become a public punching bag.

In the midst of the coronavirus pandemic, at least 303 state or local public health leaders in 41 states have resigned, retired or been fired since April 1, 2020, according to an ongoing investigation by The Associated Press and KHN.

According to experts, that is the largest exodus of public health leaders in American history.

Many left due to political blowback or pandemic pressure, as they became the target of groups that have coalesced around a common goal — fighting and even threatening officials over mask orders and well-established public health activities like quarantines and contact tracing. Some left to take higher profile positions, or due to health concerns. Others were fired for poor performance. Dozens retired. An untold number of lower level staffers have also left.

The result is a further erosion of the nation’s already fragile public health infrastructure, which KHN and the AP documented beginning in 2020 in the Underfunded and Under Threat project.

Findings

The AP and KHN found that:

• One in five Americans live in a community that has lost its local public health department leader during the pandemic
• Top public health officials in 28 states have left state-level departments ## Using this data To filter for data specific to your state, use this query

To get total numbers of exits by state, broken down by state and local departments, use this query

Methodology

KHN and AP counted how many state and local public health leaders have left their jobs between April 1, 2020 and Sept. 12, 2021.

The government tasks public health workers with improving the health of the general population, through their work to encourage healthy living and prevent infectious disease. To that end, public health officials do everything from inspecting water and food safety to testing the nation’s babies for metabolic diseases and contact tracing cases of syphilis.

Many parts of the country have a health officer and a health director/administrator by statute. The analysis counted both of those positions if they existed. For state-level departments, the count tracks people in the top and second-highest-ranking job.

The analysis includes exits of top department officials regardless of reason, because no matter the reason, each left a vacancy at the top of a health agency during the pandemic. Reasons for departures include political pressure, health concerns and poor performance. Others left to take higher profile positions or to retire. Some departments had multiple top officials exit over the course of the pandemic; each is included in the analysis.

Reporters compiled the exit list by reaching out to public health associations and experts in every state and interviewing hundreds of public health employees. They also received information from the National Association of City and County Health Officials, and combed news reports and records.

Public health departments can be found at multiple levels of government. Each state has a department that handles these tasks, but most states also have local departments that either operate under local or state control. The population served by each local health department is calculated using the U.S. Census Bureau 2019 Population Estimates based on each department’s jurisdiction.

KHN and the AP have worked since the spring on a series of stories documenting the funding, staffing and problems around public health. A previous data distribution detailed a decade's worth of cuts to state and local spending and staffing on public health. That data can be found here.

Attribution

Findings and the data should be cited as: "According to a KHN and Associated Press report."

Is Data Missing?

If you know of a public health official in your state or area who has left that position between April 1, 2020 and Sept. 12, 2021 and isn't currently in our dataset, please contact authors Anna Maria Barry-Jester annab@kff.org, Hannah Recht hrecht@kff.org, Michelle Smith mrsmith@ap.org and Lauren Weber laurenw@kff.org.

Big Data Analytics in Healthcare Market Outlook

The global market size for Big Data Analytics in Healthcare was valued at approximately USD 34 billion in 2023 and is anticipated to grow at a robust CAGR of 11.9%, reaching an estimated USD 90 billion by 2032. This remarkable growth is driven by the increasing adoption of data-driven decision-making processes within the healthcare sector, spurred by the mounting pressure to enhance operational efficiencies, improve patient outcomes, and reduce overall healthcare costs. The integration of big data analytics within healthcare systems is enabling organizations to leverage vast amounts of data, leading to enhanced patient care and streamlined operations.

A significant growth factor fueling the expansion of the big data analytics market in healthcare is the ever-increasing volume of data generated by healthcare systems. With the surge of electronic health records, wearable health devices, and various other digital health technologies, the volume of data being generated is unprecedented. This data, if analyzed correctly, holds the potential to transform healthcare delivery models, allowing for more precise diagnostics, personalized treatment plans, and proactive disease management strategies. Consequently, healthcare organizations are increasingly investing in big data analytics tools to harness this data for clinical and operational improvements.

Another key driver of market growth is the growing emphasis on value-based care and the need for healthcare providers to demonstrate high-quality patient outcomes. Value-based care models require providers to focus on the quality rather than the quantity of care delivered, inherently demanding the use of advanced analytics to derive actionable insights from patient data. Big data analytics facilitates the identification of patterns and trends that can lead to improved treatment effectiveness and patient satisfaction. This shift in care models is prompting healthcare organizations to integrate sophisticated analytics solutions that help in predictive modeling, trend analysis, and real-time decision-making, further propelling market expansion.

Additionally, the increasing incidence of chronic diseases worldwide is driving the need for more efficient healthcare services. Big data analytics in healthcare can play a critical role in managing chronic diseases by enabling preventive care and personalized treatment plans. By analyzing patient data, including historical health records, genetic information, and lifestyle choices, healthcare providers can predict potential health issues and intervene early, thereby improving patient outcomes and reducing healthcare costs. This capability is essential in managing the global burden of chronic diseases, thereby boosting the adoption of big data analytics solutions in the healthcare sector.

Regionally, North America dominates the market due to the presence of advanced healthcare infrastructure, the availability of technologically advanced products, and the high adoption rate of healthcare IT solutions. The region's robust regulatory environment and substantial investments in healthcare IT make it a fertile ground for the growth of big data analytics solutions. However, the Asia Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by increasing government initiatives supporting the digitization of healthcare, burgeoning healthcare infrastructure, and a growing focus on precision medicine. The integration of big data analytics in healthcare across diverse regions is indicative of its global importance in optimizing healthcare delivery and patient care.

Component Analysis

In the realm of big data analytics in healthcare, the component segment is vitally instrumental to the market's evolution and includes software and services. Software solutions are the backbone of big data analytics, providing healthcare organizations with the necessary tools to collect, process, and analyze vast datasets. These solutions encompass data management and analytical platforms, which are indispensable for extracting actionable insights from disparate data sources. The software component is continually evolving with advancements in artificial intelligence and machine learning, which enhance data analytics capabilities. Moreover, the increasing demand for user-friendly, customizable software solutions is driving innovation and growth within this segment.

The services component, on the other hand, plays a critical role in the implementation and maintenance of big data analytics solutions. This component includes cons

Introduction

Global Big Data in Healthcare Market size is expected to be worth around USD 145.8 Billion by 2033 from USD 42.2 Billion in 2023, growing at a CAGR of 13.2% during the forecast period from 2024 to 2033.

Big data in healthcare encompasses vast amounts of diverse, unstructured data sourced from medical journals, biometric sensors, electronic medical records (EMRs), Internet of Medical Things (IoMT), social media platforms, payer records, omics research, and data repositories. Integrating this unstructured data into traditional systems presents considerable challenges, primarily in data structuring and standardization. Effective data structuring is essential for ensuring compatibility across systems and enabling robust analytical processes.

However, advancements in big data analytics, artificial intelligence, and machine learning have significantly enhanced the ability to convert complex healthcare data into actionable insights. These advancements have transformed healthcare, driving informed decision-making, enabling early and accurate diagnostics, facilitating precision medicine, and enhancing patient engagement through digital self-service platforms, including online portals, mobile applications, and wearable health devices.

The role of big data in pharmaceutical R&D has become increasingly central, as analytics tools streamline drug discovery, accelerate clinical trial processes, and identify potential therapeutic targets more efficiently. The demand for business intelligence solutions within healthcare is rising, fueled by the surge of unstructured data and the focus on developing tailored treatment protocols. As a result, the global market for big data in healthcare is projected to grow steadily during the forecast period.

According to Cognitive Market Research, the global big data analytics in healthcare market size is USD 30251.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 17.20% from 2024 to 2031.

North America held the major market of more than 40% of the global revenue with a market size of USD 12100.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.4% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 9075.36 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 6957.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.2% from 2024 to 2031.
Latin America's market has more than 5% of the global revenue, with a market size of USD 16.6 million in 2024, and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 605.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.9% from 2024 to 2031.
The hospitals & clinics category held the highest big data analytics in healthcare market revenue share in 2024.

Market Dynamics of Big Data Analytics in Healthcare Market

Key Drivers for Big Data Analytics in Healthcare Market

Growing Use of EMR and EHR to Increase the Demand Globally:

One aspect that has contributed to the widespread implementation of EHR is government backing for their adoption, given their advantages over traditional paper-based health records. Adoption of EHRs benefits ambulatory practices and patients alike because they enhance patient care, facilitate faster access to records, and improve care coordination; increase practice efficiency and reduce costs through reduced paperwork; foster patient participation and transparency; and improve diagnostic and patient outcomes through accurate prescribing. For instance, To safeguard and legitimize digital healthcare data, the Indian government introduced the Digital Information Security in Healthcare Act (DISHA) in March 2019. The purpose of DISHA is to control the creation, gathering, storing, processing, sharing, and ownership of individually identifiable health information and patient health data. (Source: https://www.znetlive.com/blog/digital-information-security-healthcare-act-disha/).

Growing Need to Lower Medical Expenses to Propel Market Growth:

These days, rising operating costs are a problem for many hospitals and health organizations. Medical practices can operate more efficiently thanks to healthcare analytics. Reduced transcribing expenses, less time spent on paperwork, better billing documentation, fewer or no chart pulls, and storage, and better patient outcomes and care can all help cut down on operating expenses. It is said that putting this into practice saves a lot of money. Moreover, hospitals and medical practitioners can reduce unnecessary and excessive spending by utilizing analytical tools. Research has also shown that medical errors can result in billion-dollar expenses, including higher medical malpractice lawsuit costs and additional expenses for patients who require therapy to recover from errors in medicine. In addition, The application of predictive analytics can improve patient care and lower the likelihood of disease in the future. Thus, it is anticipated that the growing demand to lower operating costs in the healthcare sector will contribute to the expansion of big data analytics in healthcare market.

Key Restraint Factor for the Big Data Analytics in Healthcare Market

Rising Concerns About Safety Could Prevent Market Expansion:

The technology creates serious questions about data security and privacy, as well as about issues like fake data creation, the need for real-time protection, and its desire. Some of the current areas that require attention are the remote warehouse, improper identity management, inadequate acquisitions in the information security and systems, human error, networked appliances, and Internet of Things applications. Attempting to get around these problems is extremely difficult for associations. It is anticipated that the growing frequency of data loss incidents and cyberattacks on businesses that store customer data would hinder the industry's ability to grow. Furthermore, it is anticipated that upholding data privacy regulations such as the EU General...

Healthcare Big Data Analytics Market Outlook

The global healthcare big data analytics market size is projected to achieve a robust growth trajectory, with a valuation of approximately USD 32 billion in 2023. It is anticipated to soar to around USD 115 billion by 2032, reflecting an impressive compound annual growth rate (CAGR) of 15.4%. This remarkable growth can largely be attributed to the increasing demand for efficient data management systems in the healthcare sector, the rising need for data-driven decision-making, and the expanding adoption of analytics in diverse healthcare applications. The integration of artificial intelligence and machine learning in analytics, the emphasis on personalized medicine, and the growing importance of predictive analytics are further propelling the market forward.

One of the key growth drivers in the healthcare big data analytics market is the rising necessity for cost reduction and improved operational efficiency within the healthcare sector. Hospitals and clinics are increasingly recognizing the value of analytics in streamlining processes, reducing waste, and enhancing patient care. By leveraging big data analytics, healthcare providers can gain insights into patient care patterns, optimize resource allocation, and minimize unnecessary expenditures. This drive towards efficiency is further bolstered by government initiatives and policies aimed at improving healthcare delivery and reducing costs, creating a fertile ground for the adoption of advanced analytics solutions.

Another significant factor contributing to the market's expansion is the growing emphasis on personalized and precision medicine. As healthcare providers aim to offer more tailored treatment options, the analysis of vast datasets becomes crucial. Big data analytics facilitates the identification of patterns and trends in patient data, enabling healthcare providers to make informed decisions regarding personalized treatment plans. Moreover, the continuous advancements in genomics and biotechnology are generating immense volumes of data, necessitating robust analytics solutions to derive actionable insights. This trend towards personalized care is expected to drive substantial investments in big data analytics technologies in the coming years.

Additionally, the increasing prevalence of chronic diseases and the aging global population are driving the demand for effective population health management. Big data analytics plays a pivotal role in analyzing population health trends, identifying at-risk individuals, and devising preventive strategies. Governments and healthcare organizations are increasingly focusing on population health analytics to enhance public health outcomes and reduce the burden on healthcare infrastructure. This growing demand for comprehensive population health management solutions is expected to be a significant driving force for the healthcare big data analytics market over the forecast period.

Healthcare Analytics & Medical Analytics are becoming increasingly vital in the pursuit of personalized and precision medicine. By leveraging these analytics, healthcare providers can delve deeper into patient data to uncover insights that inform individualized treatment plans. This approach not only enhances patient outcomes but also optimizes the use of healthcare resources. As the demand for personalized care continues to rise, the role of healthcare analytics in tailoring treatments to individual patient needs is expected to grow exponentially. The integration of advanced analytics tools into healthcare systems is facilitating a shift towards more patient-centric care models, thereby driving the adoption of these technologies across the sector.

The regional outlook for the healthcare big data analytics market shows a diverse growth pattern across different geographies. North America currently holds a significant share of the market, driven by the presence of advanced healthcare infrastructure, a high level of digitalization, and a strong focus on research and development. Europe is also witnessing considerable growth, with countries like Germany and the United Kingdom leading the charge in the adoption of analytics solutions. Meanwhile, the Asia Pacific region is poised to experience the fastest growth, fueled by rapid technological advancements, increasing healthcare investments, and the need to address healthcare challenges in densely populated regions. Latin America and the Middle East & Africa are expected to show steady growth, driven by improving healthcare infrastruct

A survey of people from 31 different countries around the world found that mental health was the biggest health problem respondents said was facing their country in 2024, with around 51 percent of women and 40 percent of men considering this the case. Other health problems reported by respondents included cancer, stress, and obesity.

This data package contains dataset on prevalence rates of health conditions and diseases like obesity, diabetes and hearing loss and health risk factors for diseases like tobacco, alcohol and drug use.

A survey of women from 31 different countries around the world found that 45 percent of respondents said mental health was the biggest health problem facing their country in 2024. There was a large increase in the share of women finding mental health as the most serious health problem over the given period, rising from just 27 percent in 2018.

Connected Health M2M Market Outlook

The Connected Health M2M market size is projected to grow exponentially from USD 55 billion in 2023 to USD 180 billion by 2032, registering a CAGR of 14% during the forecast period. This growth is primarily driven by the increasing need for remote healthcare solutions and advancements in machine-to-machine (M2M) communication technologies. As healthcare providers and patients increasingly adopt connected health solutions to enhance the quality of care, the market is set to witness unprecedented growth.

The rising prevalence of chronic diseases and the aging population are significant growth factors for the Connected Health M2M market. Chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders necessitate continuous health monitoring, which connected health solutions effectively provide. The aging population also faces numerous health challenges that require ongoing attention, driving the demand for remote patient monitoring and clinical monitoring systems. By leveraging M2M technology, healthcare providers can offer continuous care, improving patient outcomes and reducing hospital readmissions.

Technological advancements in IoT, AI, and big data analytics further fuel the growth of the Connected Health M2M market. Integrating IoT devices with machine learning algorithms allows for real-time data analysis, enabling proactive healthcare management. AI-powered predictive analytics can identify potential health issues before they become critical, allowing timely intervention. Additionally, big data analytics helps in processing vast amounts of health data, providing valuable insights into patient health trends and treatment efficacy, further enhancing the effectiveness of connected health solutions.

Government initiatives and favorable regulatory frameworks also play a crucial role in the market's growth. Numerous governments worldwide are recognizing the potential of connected health solutions to improve healthcare delivery and reduce costs. As a result, they are investing in digital health infrastructure and implementing policies that promote the adoption of connected health technologies. These initiatives not only support the development of innovative solutions but also ensure their widespread deployment, thereby driving market growth.

The regional outlook for the Connected Health M2M market reveals significant growth prospects across various regions. North America dominates the market due to its advanced healthcare infrastructure, high adoption rate of new technologies, and strong focus on patient-centric care. Europe follows closely, driven by increasing government support and the presence of leading healthcare companies. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, propelled by expanding healthcare infrastructure, increasing investments in digital health, and a growing aging population.

Component Analysis

The component segment of the Connected Health M2M market is divided into Devices, Connectivity Services, Platforms, and Applications. Each sub-segment plays a vital role in the functioning and effectiveness of connected health solutions. The devices sub-segment includes a variety of medical devices and wearables that collect and transmit health data. These devices range from simple fitness trackers to complex medical monitoring equipment. The increasing development of advanced, user-friendly, and affordable devices is significantly contributing to the market's growth. Innovations like smartwatches with health monitoring features and portable ECG machines are making it easier for individuals to monitor their health continuously.

Connectivity Services are another crucial component, as they enable the seamless transmission of data between devices and healthcare providers. These services include mobile networks, Wi-Fi, Bluetooth, and other communication protocols. The reliability and efficiency of connectivity services are paramount for the real-time monitoring and analysis of health data. With advancements in 5G technology, the reliability and speed of data transmission have improved significantly, allowing for more efficient remote monitoring and telemedicine applications. Enhanced connectivity services ensure that healthcare providers receive timely and accurate data, which is essential for making informed clinical decisions.

Platforms in the Connected Health M2M market refer to the integrated systems that process, store, and analyze health data collected from various devices. These platforms o

The problem of transforming Real World Data into Real World Evidence is becoming increasingly important in the frameworks of Digital Health and Personalized Medicine, especially with the availability of modern algorithms of Artificial Intelligence high computing power, and large storage facilities.Even where Real World Data are well maintained in a hospital data warehouse and are made available for research purposes, many aspects need to be addressed to build an effective architecture enabling researchers to extract knowledge from data.We describe the first year of activity at Gemelli Generator RWD, the challenges we faced and the solutions we put in place to build a Real World Data laboratory at the service of patients and health researchers. Three classes of services are available today: retrospective analysis of existing patient data for descriptive and clustering purposes; automation of knowledge extraction, ranging from text mining, patient selection for trials, to generation of new research hypotheses; and finally the creation of Decision Support Systems, with the integration of data from the hospital data warehouse, apps, and Internet of Things.

Big Data in Healthcare Market Outlook

The global market size for Big Data in Healthcare was valued at approximately USD 32.9 billion in 2023 and is projected to reach around USD 105.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 14.1% from 2024 to 2032. This rapid expansion is driven by several growth factors including the increasing adoption of data-driven decision-making processes, the integration of advanced technologies such as AI and machine learning, and the rising demand for personalized medicine and advanced patient care.

One of the key growth factors driving the Big Data in Healthcare market is the increasing need for cost-effective treatment options and improved patient outcomes. Healthcare providers are increasingly turning to Big Data analytics to optimize their clinical workflows, reduce operational costs, and enhance the quality of care. By leveraging large datasets, healthcare professionals can identify patterns and trends that inform more accurate diagnoses, personalized treatment plans, and better patient management strategies. This transformation in healthcare delivery is expected to contribute significantly to the market's growth over the forecast period.

Another significant growth factor is the rising prevalence of chronic diseases and the need for effective disease management. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require ongoing monitoring and management, which generates vast amounts of data. Big Data analytics enables the analysis of these datasets to predict disease outbreaks, monitor patient adherence to treatment plans, and improve overall disease management. The growing emphasis on preventative healthcare and early diagnosis is further propelling the demand for Big Data analytics solutions in the healthcare sector.

Moreover, technological advancements and the increasing integration of Artificial Intelligence (AI) and machine learning (ML) into Big Data analytics are fostering market growth. AI and ML algorithms can analyze massive datasets at high speeds, uncovering insights that would be impossible to detect manually. These technologies enhance predictive analytics, clinical decision support systems, and personalized medicine, thereby driving the adoption of Big Data solutions in healthcare. The continuous development of these technologies and their application in healthcare analytics are expected to significantly boost market growth.

The regional outlook for Big Data in Healthcare indicates substantial growth across various regions, with North America leading the market due to its advanced healthcare infrastructure and high adoption rate of innovative technologies. Europe follows closely, driven by government initiatives to promote digital health and data analytics. The Asia Pacific region is expected to witness the highest growth rate, attributed to the increasing investments in healthcare infrastructure, the rising prevalence of chronic diseases, and the growing adoption of digital health solutions. Latin America and the Middle East & Africa are also expected to experience significant growth, albeit at a slower pace, due to improving healthcare systems and increasing awareness of Big Data benefits.

Component Analysis

The Big Data in Healthcare market is segmented by component into Software, Hardware, and Services. The software segment holds the largest market share, driven by the increasing demand for advanced analytics tools and platforms that facilitate data-driven decision-making in healthcare. Software solutions enable healthcare providers to collect, analyze, and visualize large datasets, improving clinical outcomes and operational efficiency. The continuous development of sophisticated analytics software and the integration of AI and ML capabilities are expected to further boost the growth of this segment.

The hardware segment, while smaller in comparison to software, plays a crucial role in the Big Data in Healthcare market. Hardware components such as servers, storage devices, and networking equipment are essential for the collection, storage, and processing of vast amounts of healthcare data. With the increasing volume of data generated by healthcare applications, there is a growing need for high-performance hardware solutions that can handle large-scale data analytics tasks. The development of advanced hardware technologies and the increasing adoption of edge computing in healthcare are expected to drive

Snapshot img

Big Data Spending In Healthcare Sector Market Size 2025-2029

The big data spending in healthcare sector market size is forecast to increase by USD 7.78 billion at a CAGR of 10.2% between 2024 and 2029.

The market is driven by the growing need to improve business efficiency and the increasing use of big data analytics in healthcare. The healthcare industry is generating vast amounts of data daily, and harnessing this data through analytics can lead to enhanced patient care, operational efficiency, and research advancements. However, this trend faces significant challenges. Consumer behavior and customer experience are also under scrutiny, with data talent and natural language processing essential for last-mile delivery of personalized services.
Companies must navigate these complexities to effectively leverage data for improved patient outcomes and operational excellence. Ensuring the protection of sensitive health information is crucial to maintain patient trust and adhere to regulatory requirements. Data security and privacy concerns related to patients' medical data are becoming increasingly prominent. As the healthcare sector continues to digitize, addressing these challenges while capitalizing on the opportunities presented by big data analytics will be essential for market success. 

What will be the Size of the Big Data Spending In Healthcare Sector Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

In the dynamic healthcare sector, the adoption of big data has become a key driver for innovation and improvement. The market is witnessing significant investments in structured and unstructured data integration, ensuring data quality and security for data-driven decision-making. Risk management is a major focus, with predictive modeling and continuous intelligence enabling early fraud detection. The variety and velocity of data require advanced data analytics and machine learning techniques for effective decision-making. Data management and storage solutions in the cloud are increasingly popular due to their scalability and flexibility.

Semi-structured data and artificial intelligence are revolutionizing data visualization and enabling more accurate predictions, enhancing the overall value of big data in healthcare. The healthcare sector's big data landscape is continuously unfolding, with new applications and challenges emerging. Data integration and analytics are essential for making informed business decisions and improving patient care.

How is this Big Data Spending In Healthcare Sector Industry segmented?

The big data spending in healthcare sector industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Service

  Services
  Software


Type

  Descriptive analytics
  Predictive analytics
  Prescriptive analytics
  Diagnostic analytics


Application

  Financial analytics
  Population health management
  Clinical decision support
  Operational analytics
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Ireland
    UK


  APAC

    China
    India
    Philippines


  South America

    Brazil


  Rest of World (ROW)

By Service Insights

The Services segment is estimated to witness significant growth during the forecast period. In the dynamic healthcare sector, the adoption of big data solutions is increasingly becoming a priority for organizations. The services segment, which includes professional services, consulting, and managed services, is experiencing significant growth. Professional services, offered by third-party analytics companies, provide tailor-made solutions for the healthcare industry. These services enable organizations to discover new revenue streams, enhance data security, and improve service support for increased productivity. The demand for industry-specific, consumer group-specific, and region-specific data analysis is on the rise due to intensifying competition and innovation. Consulting services, though holding a smaller revenue share, significantly contribute to the overall growth of the services segment.

Flexibility, continuous intelligence, and data visualization are crucial elements of these services, ensuring business value in the face of data volume and variety. Risk management, cyber attacks, data quality, and data breaches are major concerns, necessitating advanced solutions like AI, machine learning, and natural language processing. Data collection, data storage, and data integration are essential components of data management, which must address velocity, noise, and data overload. Cloud services, data la

The Real World Data (RWD) solution market is experiencing robust growth, driven by the increasing adoption of digital health technologies, the rising prevalence of chronic diseases, and the urgent need for more efficient and cost-effective clinical trials. The market's expansion is fueled by several key factors, including the growing availability of large datasets from electronic health records (EHRs), wearable sensors, and mobile health applications. Pharmaceutical and biotechnology companies are increasingly leveraging RWD to accelerate drug development, gain deeper insights into patient populations, and improve post-market surveillance. Furthermore, regulatory agencies are showing greater acceptance of RWD in clinical decision-making, further stimulating market growth. We estimate the market size to be approximately $15 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 18% projected through 2033. This growth is anticipated to be driven primarily by the increased integration of AI and machine learning into RWD platforms, enhancing data analysis and generating actionable insights. The market is segmented by application (e.g., clinical trials, drug safety surveillance, regulatory submissions, payer decision support) and by type of data (e.g., EHRs, claims data, patient-generated health data, registry data). North America currently holds a significant share of the global RWD market, due to advanced healthcare infrastructure and early adoption of digital health technologies. However, Asia-Pacific is projected to witness the highest growth rate in the forecast period, driven by rapid technological advancements and increasing healthcare expenditure in emerging economies like India and China. Significant restraints include data privacy concerns, data interoperability challenges, and the need for robust data governance frameworks to ensure data quality and security. However, ongoing technological advancements and supportive regulatory policies are expected to mitigate these challenges in the coming years. Key players in the market are actively investing in RWD solutions, strengthening their competitive landscape through strategic partnerships, mergers, and acquisitions.

Big Data Analytics for Clinical Research Market Outlook

As per our latest research, the Big Data Analytics for Clinical Research market size reached USD 7.45 billion globally in 2024, reflecting a robust adoption pace driven by the increasing digitization of healthcare and clinical trial processes. The market is forecasted to grow at a CAGR of 17.2% from 2025 to 2033, reaching an estimated USD 25.54 billion by 2033. This significant growth is primarily attributed to the rising need for real-time data-driven decision-making, the proliferation of electronic health records (EHRs), and the growing emphasis on precision medicine and personalized healthcare solutions. The industry is experiencing rapid technological advancements, making big data analytics a cornerstone in transforming clinical research methodologies and outcomes.

Several key growth factors are propelling the expansion of the Big Data Analytics for Clinical Research market. One of the primary drivers is the exponential increase in clinical data volumes from diverse sources, including EHRs, wearable devices, genomics, and imaging. Healthcare providers and research organizations are leveraging big data analytics to extract actionable insights from these massive datasets, accelerating drug discovery, optimizing clinical trial design, and improving patient outcomes. The integration of artificial intelligence (AI) and machine learning (ML) algorithms with big data platforms has further enhanced the ability to identify patterns, predict patient responses, and streamline the entire research process. These technological advancements are reducing the time and cost associated with clinical research, making it more efficient and effective.

Another significant factor fueling market growth is the increasing collaboration between pharmaceutical & biotechnology companies and technology firms. These partnerships are fostering the development of advanced analytics solutions tailored specifically for clinical research applications. The demand for real-world evidence (RWE) and real-time patient monitoring is rising, particularly in the context of post-market surveillance and regulatory compliance. Big data analytics is enabling stakeholders to gain deeper insights into patient populations, treatment efficacy, and adverse event patterns, thereby supporting evidence-based decision-making. Furthermore, the shift towards decentralized and virtual clinical trials is creating new opportunities for leveraging big data to monitor patient engagement, adherence, and safety remotely.

The regulatory landscape is also evolving to accommodate the growing use of big data analytics in clinical research. Regulatory agencies such as the FDA and EMA are increasingly recognizing the value of data-driven approaches for enhancing the reliability and transparency of clinical trials. This has led to the establishment of guidelines and frameworks that encourage the adoption of big data technologies while ensuring data privacy and security. However, the implementation of stringent data protection regulations, such as GDPR and HIPAA, poses challenges related to data integration, interoperability, and compliance. Despite these challenges, the overall outlook for the Big Data Analytics for Clinical Research market remains highly positive, with sustained investments in digital health infrastructure and analytics capabilities.

From a regional perspective, North America currently dominates the Big Data Analytics for Clinical Research market, accounting for the largest share due to its advanced healthcare infrastructure, high adoption of digital technologies, and strong presence of leading pharmaceutical companies. Europe follows closely, driven by increasing government initiatives to promote health data interoperability and research collaborations. The Asia Pacific region is emerging as a high-growth market, supported by expanding healthcare IT investments, rising clinical trial activities, and growing awareness of data-driven healthcare solutions. Latin America and the Middle East & Africa are also witnessing gradual adoption, albeit at a slower pace, due to infrastructural and regulatory challenges. Overall, the global market is poised for substantial growth across all major regions over the forecast period.

Women's Health Market Outlook

The global women's health market size is projected to grow from USD 42.68 billion in 2023 to USD 72.10 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.3% over the forecast period. The growth of this market is primarily driven by increasing awareness about women's health issues, advancements in medical technology, and the rising prevalence of chronic diseases among women. Factors such as the growing geriatric female population and an increasing focus on preventive healthcare are also crucial drivers of market expansion.

One of the key growth factors in the women's health market is the increasing awareness and education regarding women's health issues. Governments and non-profit organizations across the globe are implementing programs and campaigns to educate women about the importance of regular health check-ups and early diagnosis of diseases. These initiatives have led to a higher demand for women's health services and products. Furthermore, the growing focus on women's health in medical research has resulted in the development of new and more effective treatments, thereby boosting market growth.

Technological advancements in the healthcare sector are significantly contributing to the growth of the women's health market. Innovations such as minimally invasive surgical devices, advanced diagnostic tools, and personalized medicine are enhancing the quality of care provided to women. For instance, the advent of robotic-assisted surgeries has revolutionized gynecological procedures, making them safer and more efficient. Additionally, the development of targeted therapies for conditions such as breast cancer and osteoporosis is improving treatment outcomes, thereby driving market growth.

The rising prevalence of chronic diseases among women is another major factor propelling the growth of the women's health market. Conditions such as breast cancer, cervical cancer, osteoporosis, and menopause-related issues are becoming increasingly common among women. The increasing burden of these diseases is leading to a higher demand for diagnostic and therapeutic products and services. Additionally, lifestyle-related factors such as poor diet, lack of physical activity, and stress are contributing to the rising incidence of chronic diseases among women, further driving the market.

Regionally, North America holds the largest share of the women's health market, owing to the well-established healthcare infrastructure, high healthcare expenditure, and the presence of major market players in the region. Europe follows closely, driven by increasing government initiatives and rising awareness about women's health. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, attributed to the growing population, increasing disposable income, and improving healthcare infrastructure. The market in Latin America and the Middle East & Africa is also anticipated to grow steadily, driven by the rising prevalence of chronic diseases and increasing awareness about women's health.

Product Type Analysis

The women's health market is segmented into diagnostics, therapeutics, surgical devices, and others based on product type. The diagnostics segment includes various products and tests used for early detection and diagnosis of diseases specific to women, such as mammograms, pap smears, and bone density tests. This segment is expected to witness significant growth due to the increasing emphasis on preventive healthcare and early diagnosis. The rising prevalence of breast and cervical cancer has led to a higher demand for diagnostic tests, thereby boosting the growth of this segment.

The therapeutics segment encompasses a wide range of medications and treatments used to manage and treat various women's health conditions. This includes hormonal therapies, contraceptives, osteoporosis treatments, and cancer therapies. The increasing incidence of chronic diseases among women, coupled with advancements in therapeutic options, is driving the growth of this segment. The introduction of new and more effective treatments, such as targeted therapies for breast cancer, is further propelling the market. Additionally, the growing focus on personalized medicine is expected to boost the demand for therapeutic products in the women's health market.

Surgical devices play a crucial role in the treatment of various women's health conditions, particularly in gynecological surgeries. This segment includes a wi

Please cite the following paper when using this dataset: N. Thakur, “MonkeyPox2022Tweets: The first public Twitter dataset on the 2022 MonkeyPox outbreak,” Preprints, 2022, DOI: 10.20944/preprints202206.0172.v2

Abstract The world is currently facing an outbreak of the monkeypox virus, and confirmed cases have been reported from 28 countries. Following a recent “emergency meeting”, the World Health Organization just declared monkeypox a global health emergency. As a result, people from all over the world are using social media platforms, such as Twitter, for information seeking and sharing related to the outbreak, as well as for familiarizing themselves with the guidelines and protocols that are being recommended by various policy-making bodies to reduce the spread of the virus. This is resulting in the generation of tremendous amounts of Big Data related to such paradigms of social media behavior. Mining this Big Data and compiling it in the form of a dataset can serve a wide range of use-cases and applications such as analysis of public opinions, interests, views, perspectives, attitudes, and sentiment towards this outbreak. Therefore, this work presents MonkeyPox2022Tweets, an open-access dataset of Tweets related to the 2022 monkeypox outbreak that were posted on Twitter since the first detected case of this outbreak on May 7, 2022. The dataset is compliant with the privacy policy, developer agreement, and guidelines for content redistribution of Twitter, as well as with the FAIR principles (Findability, Accessibility, Interoperability, and Reusability) principles for scientific data management.

Data Description The dataset consists of a total of 255,363 Tweet IDs of the same number of tweets about monkeypox that were posted on Twitter from 7th May 2022 to 23rd July 2022 (the most recent date at the time of dataset upload). The Tweet IDs are presented in 6 different .txt files based on the timelines of the associated tweets. The following provides the details of these dataset files. • Filename: TweetIDs_Part1.txt (No. of Tweet IDs: 13926, Date Range of the Tweet IDs: May 7, 2022 to May 21, 2022) • Filename: TweetIDs_Part2.txt (No. of Tweet IDs: 17705, Date Range of the Tweet IDs: May 21, 2022 to May 27, 2022) • Filename: TweetIDs_Part3.txt (No. of Tweet IDs: 17585, Date Range of the Tweet IDs: May 27, 2022 to June 5, 2022) • Filename: TweetIDs_Part4.txt (No. of Tweet IDs: 19718, Date Range of the Tweet IDs: June 5, 2022 to June 11, 2022) • Filename: TweetIDs_Part5.txt (No. of Tweet IDs: 47718, Date Range of the Tweet IDs: June 12, 2022 to June 30, 2022) • Filename: TweetIDs_Part6.txt (No. of Tweet IDs: 138711, Date Range of the Tweet IDs: July 1, 2022 to July 23, 2022)

The dataset contains only Tweet IDs in compliance with the terms and conditions mentioned in the privacy policy, developer agreement, and guidelines for content redistribution of Twitter. The Tweet IDs need to be hydrated to be used.